MCH ACIEP-R is a specialized pain relief medication that combines aceclofenac and rabeprazole, designed to provide effective pain management for a variety of conditions. It is commonly used to relieve pain and inflammation associated with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Additionally, MCH ACIEP-R is effective in alleviating acute pain, including toothache, lower back pain, and ear and throat discomfort. This combination formula offers both anti-inflammatory and acid-protective benefits, making it suitable for patients requiring long-term pain management.
Aceclofenac: Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation. It works by inhibiting the release of certain chemicals in the body that cause pain, making it effective for managing chronic inflammatory conditions like arthritis and other musculoskeletal disorders.
Rabeprazole: Rabeprazole is a proton pump inhibitor (PPI) included in MCH ACIEP-R to protect the stomach lining. By reducing stomach acid production, rabeprazole minimizes the risk of gastric irritation often associated with NSAID use, providing an added layer of protection for those with sensitive stomachs or those requiring extended pain management.
Targeted pain relief: MCH ACIEP-R effectively alleviates pain from various conditions, including rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, lower back pain, and dental pain.
Reduced inflammation: Aceclofenac helps decrease inflammation, allowing for better mobility and relief from joint stiffness and swelling.
Gastroprotection: Rabeprazole protects the stomach lining, reducing the likelihood of gastric side effects and enabling safer long-term use.
Improved quality of life: By managing pain and inflammation, MCH ACIEP-R helps patients maintain daily activities with greater ease and comfort.
MCH ACIEP-R is typically well-tolerated, but some users may experience side effects such as nausea, dizziness, or abdominal discomfort. Prolonged use of NSAIDs may lead to increased risk of gastrointestinal bleeding, kidney issues, or cardiovascular events; rabeprazole helps to mitigate these risks by protecting the stomach lining. MCH ACIEP-R is not recommended for those allergic to NSAIDs, aceclofenac, or rabeprazole, or for individuals with certain gastrointestinal or cardiovascular conditions. Patients should consult their healthcare provider if they have any pre-existing medical conditions or are taking other medications to avoid potential interactions.
MCH ACIEP-R by Medicox Life Science offers an innovative, dual-action solution for pain relief with built-in stomach protection. Combining the analgesic power of aceclofenac with the acid-suppressing properties of rabeprazole, MCH ACIEP-R provides an effective and safer approach for individuals requiring ongoing pain management. Medicox Life Science ensures the highest standards in formulation and quality, making MCH ACIEP-R a reliable choice for both short- and long-term pain relief needs.
We offer a range of pain relief solutions designed to tackle everything from mild headaches to intense joint and muscle pain. Whether it’s tablets, capsules, or gels, our products are crafted for quick and effective relief, helping you expand your reach with trusted solutions under our Pharma Franchise program.
Join as a partner, dealer, or distributor to deliver quality healthcare solutions across India.
Get in Touch